Bringing a potential new medicine into human clinical development for the first time is one of the most exciting, but challenging, jobs for a pharmacologist or experimental medicine physician. This virtual training workshop will cover the core principles of early phase drug development from the first study in humans through to efficacy assessments in Phase 2.
This training day is ideal for postgraduate students, physicians and professional scientists working in academic, clinical or industry settings who have an interest in understanding early phase drug development and how to take a molecule through from late discovery to the start of Phase 3.
Following this training day, the participant will be able to:
- Compare and contrast different molecules based on their pharmacological and physicochemical properties to select the most appropriate candidate to take forward into Phase I clinical development
- Describe the principles of protecting participant safety in first time-in-human and other early phase trials
- Identify key statistical considerations that apply to early phase drug trials
- Describe the role and implementation of futility analysis, prior elicitation and quantitative decision making interactions
For further information and to see the full programme, please visit the BPS event page
Cost and booking
Member early bird £110
Member standard £145
Non-member early bird £155
Non-member standard £195
Advance registration is essential through the BPS event page
. Registrations will close on 4th November.
For event queries, contact the BPS Education team at email@example.com
or on +44 20 7239 0170.